Scheme 1From: Theranostic nanoplatform to target macrophages enables the inhibition of atherosclerosis progression and fluorescence imaging of plaque in ApoE(−/−) miceSchematic illustration of CMSN@SRT@Anti formation process. The fluorescent CMSN was used as nanocarrier to load SRT1720 and conjugate with AntiCD36 to obtain the theranostic nanomaterialsBack to article page